Institutional investors purchased a net $13.9 million shares of RNN during the quarter ended March 2016, and now own 17.48% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 13.2 Million shares of Rexahn Pharmaceuticals In...